Member Info for donnodertrader

Pathetic!

Oh give it a rest!!!!

Share Price: 1,185.00Bid: 1,105.00Ask: 1,185.00Change: 45.00 (3.95%)

H H well said

Interactive investor is giving 1415 too

It is no longer 910 on II it is now 790!!!!!!

Bearded dragon i still have that post here it is

Would someone kindly explain why the share price has rocketed to 550p only a few days after a 180p placing. It doesn't make sense. Surely they should have set the placing at a much higher level. My guess is that another will follow very soon, possibly in the 3-400p range.

They have treated the shareholders with disdain. AND This rns could have come out earlier

Great thinking. MHB

thanks MHB for reminding us of these questions.

i do not question their scientific excellence; but i want to be reassured about their capacity to attract the funding to turn that scientific excellence into positive outcomes, both medical and financial.

i have been following the debate, but i am now firming up on a NO, as merely trust in the BoD is not sufficient, in my view, to authorise a potential dilution of share value. For this to change to a YES would require a specific reasoned case to allow us to evaluate its merits. In the absence of that, it remains a NO. Let's remember the BoD currently have capacity to issue more shares, albeit at a lower level.

of course you are accused of being rude, because a lot of the time you are. you then set the tone in which other people reply.

For the sake of decency can you just cut out the unnecessary attacks and make your point in a polite fashion?

it is not a binary issue of trusting management or not: it is about encouraging their direction of travel.

the rudeness is creeping in again. There is no need to attack posters just to make a point!

Good points. I hope they will be pursued at the next Agm!

Thanks Michael for pointing out the importance of the word 'pivotal'. Food for thought!

MHB
...And as I think about it further, I fully agree with your conclusion. It really reinforces 4D's claim of being a global leader in LBPs and oncology especially.

Looking forward to 0518 & Keytruda combo data on the other oncology indications.

Onwards and upwards!

Good luck all genuine investors.

thanks Michael. I had not thought of the possible overlap of the numbers, but i am glad that you did. It was good that you were able to get this clarified, and in such positive way. thanks again

Axel. i dont think you have a longitudinal view. I think MHB is frustrated that Sanj dilutes the importance of his potential knowledgeable contribution when he ridicules and puts down other contributors. I share that frustration, as he has provided useful scientific knowledge.

well said MHB